CA2134327C - Rectifying dialyzer, bioreactor and membrane - Google Patents
Rectifying dialyzer, bioreactor and membrane Download PDFInfo
- Publication number
- CA2134327C CA2134327C CA002134327A CA2134327A CA2134327C CA 2134327 C CA2134327 C CA 2134327C CA 002134327 A CA002134327 A CA 002134327A CA 2134327 A CA2134327 A CA 2134327A CA 2134327 C CA2134327 C CA 2134327C
- Authority
- CA
- Canada
- Prior art keywords
- membranes
- membrane
- interior
- skins
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 129
- 238000007873 sieving Methods 0.000 claims abstract description 63
- 229920000642 polymer Polymers 0.000 claims abstract description 26
- 238000001914 filtration Methods 0.000 claims abstract description 21
- 238000000502 dialysis Methods 0.000 claims abstract description 19
- 239000011148 porous material Substances 0.000 claims abstract description 19
- 235000015097 nutrients Nutrition 0.000 claims abstract description 8
- 210000004379 membrane Anatomy 0.000 claims description 120
- 239000012530 fluid Substances 0.000 claims description 78
- 239000000835 fiber Substances 0.000 claims description 45
- 238000004891 communication Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 239000002952 polymeric resin Substances 0.000 claims description 12
- 229920003002 synthetic resin Polymers 0.000 claims description 12
- 229920002492 poly(sulfone) Polymers 0.000 claims description 8
- 239000002699 waste material Substances 0.000 claims description 8
- 239000004697 Polyetherimide Substances 0.000 claims description 4
- 230000005012 migration Effects 0.000 claims description 4
- 238000013508 migration Methods 0.000 claims description 4
- 229920001601 polyetherimide Polymers 0.000 claims description 4
- 239000012510 hollow fiber Substances 0.000 abstract description 20
- 239000000463 material Substances 0.000 abstract description 7
- 230000035699 permeability Effects 0.000 abstract description 2
- 238000011027 product recovery Methods 0.000 abstract 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 29
- 239000000706 filtrate Substances 0.000 description 27
- 239000000243 solution Substances 0.000 description 26
- 239000002904 solvent Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 229920002307 Dextran Polymers 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 208000012886 Vertigo Diseases 0.000 description 10
- 238000009987 spinning Methods 0.000 description 10
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 9
- 102100030856 Myoglobin Human genes 0.000 description 8
- 108010062374 Myoglobin Proteins 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000701 coagulant Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000004382 potting Methods 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010075031 Cytochromes c Proteins 0.000 description 2
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 2
- 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000002441 uremic toxin Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/24—Dialysis ; Membrane extraction
- B01D61/243—Dialysis
- B01D61/244—Dialysis comprising multiple dialysis steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/16—Hollow fibers
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Water Supply & Treatment (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- External Artificial Organs (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2840093A | 1993-03-09 | 1993-03-09 | |
| US8/028,400 | 1993-03-09 | ||
| PCT/US1994/002126 WO1994020603A1 (en) | 1993-03-09 | 1994-02-28 | Rectifying dialyzer, bioreactor and membrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2134327A1 CA2134327A1 (en) | 1994-09-15 |
| CA2134327C true CA2134327C (en) | 2003-12-02 |
Family
ID=21843256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002134327A Expired - Fee Related CA2134327C (en) | 1993-03-09 | 1994-02-28 | Rectifying dialyzer, bioreactor and membrane |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0644928B1 (enExample) |
| JP (1) | JP3396034B2 (enExample) |
| KR (1) | KR100304224B1 (enExample) |
| CN (1) | CN1056645C (enExample) |
| AT (1) | ATE181357T1 (enExample) |
| CA (1) | CA2134327C (enExample) |
| DE (1) | DE69419095T2 (enExample) |
| ES (1) | ES2135569T3 (enExample) |
| TW (1) | TW243417B (enExample) |
| WO (1) | WO1994020603A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5480552A (en) * | 1992-01-10 | 1996-01-02 | Baxter International Inc. | Method for concentrating a solute with an oscillating filtration device |
| JP3714686B2 (ja) * | 1994-04-27 | 2005-11-09 | 旭化成メディカル株式会社 | ポリスルホン系中空糸膜及びその製造方法 |
| EP0894852B1 (de) * | 1997-07-31 | 2004-01-28 | Roche Diagnostics GmbH | Verfahren und Vorrichtung zur Durchführung biochemischer Reaktionen |
| EP2200931B1 (en) | 2007-09-19 | 2017-06-07 | The Charles Stark Draper Laboratory, Inc. | Microfluidic structures with circular cross-section |
| US20110082563A1 (en) * | 2009-10-05 | 2011-04-07 | The Charles Stark Draper Laboratory, Inc. | Microscale multiple-fluid-stream bioreactor for cell culture |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60246812A (ja) * | 1984-05-18 | 1985-12-06 | Daicel Chem Ind Ltd | ポリスルホン系樹脂製中空糸 |
| JPS62500356A (ja) * | 1984-10-09 | 1987-02-19 | エンドトロニツクス インコ−ポレ−テツド | 栄養素の潅流および生成物の濃度を改良した中空繊維培養装置および運転方法 |
| EP0201604B1 (en) * | 1984-10-30 | 1991-08-28 | Teijin Limited | Permselective hollow yarn membrane, method of producing the same, method of separating plasma components, and plasma component separator |
| EP0294737B1 (en) * | 1987-06-12 | 1994-09-21 | Kuraray Co., Ltd. | Polysulfone hollow fiber membrane and process for making the same |
| FR2640638B1 (fr) * | 1988-12-20 | 1991-02-15 | Commissariat Energie Atomique | Bioreacteur et dispositif pour la culture de cellules animales |
| US5240614A (en) * | 1992-01-10 | 1993-08-31 | Baxter International Inc. | Process for removing unwanted materials from fluids and for producing biological products |
-
1994
- 1994-02-28 WO PCT/US1994/002126 patent/WO1994020603A1/en not_active Ceased
- 1994-02-28 AT AT94910773T patent/ATE181357T1/de not_active IP Right Cessation
- 1994-02-28 ES ES94910773T patent/ES2135569T3/es not_active Expired - Lifetime
- 1994-02-28 CA CA002134327A patent/CA2134327C/en not_active Expired - Fee Related
- 1994-02-28 CN CN94190114A patent/CN1056645C/zh not_active Expired - Fee Related
- 1994-02-28 JP JP52008094A patent/JP3396034B2/ja not_active Expired - Fee Related
- 1994-02-28 KR KR1019940703991A patent/KR100304224B1/ko not_active Expired - Fee Related
- 1994-02-28 DE DE69419095T patent/DE69419095T2/de not_active Expired - Lifetime
- 1994-02-28 EP EP94910773A patent/EP0644928B1/en not_active Expired - Lifetime
- 1994-03-16 TW TW083102262A patent/TW243417B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2135569T3 (es) | 1999-11-01 |
| CA2134327A1 (en) | 1994-09-15 |
| CN1056645C (zh) | 2000-09-20 |
| JP3396034B2 (ja) | 2003-04-14 |
| KR100304224B1 (ko) | 2001-11-22 |
| EP0644928B1 (en) | 1999-06-16 |
| JPH07506496A (ja) | 1995-07-20 |
| DE69419095T2 (de) | 2000-02-03 |
| ATE181357T1 (de) | 1999-07-15 |
| CN1103745A (zh) | 1995-06-14 |
| KR950701378A (ko) | 1995-03-23 |
| TW243417B (enExample) | 1995-03-21 |
| WO1994020603A1 (en) | 1994-09-15 |
| EP0644928A1 (en) | 1995-03-29 |
| DE69419095D1 (de) | 1999-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5527467A (en) | Rectifying dialyzer, bioreactor and membrane | |
| EP0576659B1 (en) | Membrane, rectifying dialyzer, bioreactor and the relevant use thereof | |
| EP0692996B1 (en) | A method for concentrating a solute by continually altering the filtration direction through an asymmetric memrane | |
| EP0294737B1 (en) | Polysulfone hollow fiber membrane and process for making the same | |
| EP2845641B1 (en) | Permselective asymmetric membranes with high molecular weight polyvinylpyrrolidone, the preparation and use thereof | |
| US6042783A (en) | Hollow yarn membrane used for blood purification and blood purifier | |
| CN100457242C (zh) | 改良的除去中分子的透析膜 | |
| CA2149418C (en) | High flux hollow fiber membrane | |
| CA2134327C (en) | Rectifying dialyzer, bioreactor and membrane | |
| JP4003982B2 (ja) | ポリスルホン系選択透過性分離膜 | |
| JP2001038172A (ja) | 中空糸型選択分離膜 | |
| KR20010073727A (ko) | 혈액투석용 폴리설폰계 중공사막 | |
| JPH10230147A (ja) | 選択透過性分離膜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |